O'Shaughnessy Asset Management, LLC Reata Pharmaceuticals Inc Transaction History

O'Shaughnessy Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$25.61 - $110.96 $16,544 - $71,680	-646 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$100.0 - $143.02 $63,600 - $90,960	636 Added 6360.0%	646 $65,000
Q4 2020 Feb 11, 2021	SELL	$102.03 - $184.62 $102,438 - $185,358	-1,004 Reduced 99.01%	10 $1,000
Q3 2020 Nov 12, 2020	SELL	$93.53 - $163.34 $8,324 - $14,537	-89 Reduced 8.07%	1,014 $99,000
Q2 2020 Aug 13, 2020	SELL	$126.3 - $176.56 $35,995 - $50,319	-285 Reduced 20.53%	1,103 $172,000
Q1 2020 May 13, 2020	SELL	$124.16 - $247.74 $869 - $1,734	-7 Reduced 0.5%	1,388 $201,000
Q4 2019 Feb 12, 2020	BUY	$74.57 - $217.92 $104,025 - $303,998	1,395 New	1,395 $285,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.